Form 4 for LXEO Lexeo Therapeutics, Inc.
Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-25 · accession 0001415889-24-027746 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-26 | 2024-11-25 | LXEO | CHOLMONDELEY PAULA H | Dir | P - Purchase | $6.99 | +15.0K | 30.6K | +96% | +$104.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-25 | P | A | 15,000 | $6.99 | 30,627 | D | — | — | (F1) 15,627 of the shares are subject to vesting and vest at the following rate: 1/48th of the shares vested or vest in monthly installments commencing on December 1, 2021, subject to the Reporting Person's continuous service. |